Whole-genome sequencing (WGS) brings comprehensive insights to cancer genome
interpretation. To explore the clinical value of WGS, we sequenced 254 triple-negative breast …

Background A mutation found in the BRCA1 or BRCA2 gene of a breast tumor could be either
germline or somatically acquired. The prevalence of somatic BRCA1/2 mutations and the …

Background Breast cancer exhibits significant molecular, pathological, and clinical
heterogeneity. Current clinicopathological evaluation is imperfect for predicting outcome, which …

Purpose In early breast cancer (BC), five conventional biomarkers—estrogen receptor (ER),
progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), Ki67, and …

The trace element selenium is of essential importance for the synthesis of a set of redox
active proteins. We investigated three complementary serum selenium status biomarkers in …

Background We and others have recently shown that tumor characteristics are altered
throughout tumor progression. These findings emphasize the need for re-examination of tumor …

Background Accurate classification of breast cancer using gene expression profiles has
contributed to a better understanding of the biological mechanisms behind the disease and has …

Homologous recombination deficiency (HRD) is a defining characteristic in BRCA-deficient
breast tumors caused by genetic or epigenetic alterations in key pathway genes. We …

Objective To investigate the relationship between tumour stage at diagnosis and selected
components of primary and secondary care in the diagnostic interval for breast, colorectal, …

Multigene assays for molecular subtypes and biomarkers can aid management of early
invasive breast cancer. Using RNA-sequencing we aimed to develop single-sample predictor (…